These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

400 related items for PubMed ID: 23015068

  • 1. Synthesis of iridium and ruthenium complexes with (N,N), (N,O) and (O,O) coordinating bidentate ligands as potential anti-cancer agents.
    Lucas SJ, Lord RM, Wilson RL, Phillips RM, Sridharan V, McGowan PC.
    Dalton Trans; 2012 Dec 07; 41(45):13800-2. PubMed ID: 23015068
    [Abstract] [Full Text] [Related]

  • 2. Arene ruthenium complexes as anticancer agents.
    Süss-Fink G.
    Dalton Trans; 2010 Feb 21; 39(7):1673-88. PubMed ID: 20449402
    [Abstract] [Full Text] [Related]

  • 3. Biological activity of neutral and cationic iridium(III) complexes with κP and κP,κS coordinated Ph₂PCH₂S(O)xPh (x = 0-2) ligands.
    Ludwig G, Mijatović S, Ranđelović I, Bulatović M, Miljković D, Maksimović-Ivanić D, Korb M, Lang H, Steinborn D, Kaluđerović GN.
    Eur J Med Chem; 2013 Nov 21; 69():216-22. PubMed ID: 24042044
    [Abstract] [Full Text] [Related]

  • 4. Rhodium, iridium, and ruthenium half-sandwich picolinamide complexes as anticancer agents.
    Almodares Z, Lucas SJ, Crossley BD, Basri AM, Pask CM, Hebden AJ, Phillips RM, McGowan PC.
    Inorg Chem; 2014 Jan 21; 53(2):727-36. PubMed ID: 24397747
    [Abstract] [Full Text] [Related]

  • 5. Synthesis and evaluation of new salicylaldehyde-2-picolinylhydrazone Schiff base compounds of Ru(II), Rh(III) and Ir(III) as in vitro antitumor, antibacterial and fluorescence imaging agents.
    Palepu NR, Nongbri SL, Premkumar JR, Verma AK, Bhattacharjee K, Joshi SR, Forbes S, Mozharivskyj Y, Thounaojam R, Aguan K, Kollipara MR.
    J Biol Inorg Chem; 2015 Jun 21; 20(4):619-38. PubMed ID: 25712889
    [Abstract] [Full Text] [Related]

  • 6. Structure-activity relationships for cytotoxic ruthenium(II) arene complexes containing N,N-, N,O-, and O,O-chelating ligands.
    Habtemariam A, Melchart M, Fernandez R, Parsons S, Oswald ID, Parkin A, Fabbiani FP, Davidson JE, Dawson A, Aird RE, Jodrell DI, Sadler PJ.
    J Med Chem; 2006 Nov 16; 49(23):6858-68. PubMed ID: 17154516
    [Abstract] [Full Text] [Related]

  • 7. Novel ruthenium complexes ligated with 4-anilinoquinazoline derivatives: synthesis, characterisation and preliminary evaluation of biological activity.
    Ji L, Zheng W, Lin Y, Wang X, Lü S, Hao X, Luo Q, Li X, Yang L, Wang F.
    Eur J Med Chem; 2014 Apr 22; 77():110-20. PubMed ID: 24631730
    [Abstract] [Full Text] [Related]

  • 8. Ruthenium(II) carbonyl complexes containing S-methylisothiosemicarbazone based tetradentate ligand: synthesis, characterization and biological applications.
    Selvamurugan S, Ramachandran R, Viswanathamurthi P.
    Biometals; 2013 Oct 22; 26(5):741-53. PubMed ID: 23780567
    [Abstract] [Full Text] [Related]

  • 9. Synthesis of organometallic ruthenium(II) complexes with strong activity against several human cancer cell lines.
    Morais TS, Silva TJ, Marques F, Robalo MP, Avecilla F, Amorim Madeira PJ, Mendes PJ, Santos I, Garcia MH.
    J Inorg Biochem; 2012 Sep 22; 114():65-74. PubMed ID: 22698866
    [Abstract] [Full Text] [Related]

  • 10. Derivation of structure-activity relationships from the anticancer properties of ruthenium(II) arene complexes with 2-aryldiazole ligands.
    Martínez-Alonso M, Busto N, Jalón FA, Manzano BR, Leal JM, Rodríguez AM, García B, Espino G.
    Inorg Chem; 2014 Oct 20; 53(20):11274-88. PubMed ID: 25302401
    [Abstract] [Full Text] [Related]

  • 11. Trans titanium(IV) complexes of salen ligands exhibit high antitumor activity.
    Tzubery A, Tshuva EY.
    Inorg Chem; 2011 Sep 05; 50(17):7946-8. PubMed ID: 21797239
    [Abstract] [Full Text] [Related]

  • 12. Half-Sandwich Iridium(III) and Ruthenium(II) Complexes Containing P^P-Chelating Ligands: A New Class of Potent Anticancer Agents with Unusual Redox Features.
    Li J, Tian M, Tian Z, Zhang S, Yan C, Shao C, Liu Z.
    Inorg Chem; 2018 Feb 19; 57(4):1705-1716. PubMed ID: 29400963
    [Abstract] [Full Text] [Related]

  • 13. Study of ruthenium(II) complexes with anticancer drugs as ligands. Design of metal-based phototherapeutic agents.
    Cini R, Tamasi G, Defazio S, Corsini M, Zanello P, Messori L, Marcon G, Piccioli F, Orioli P.
    Inorg Chem; 2003 Dec 01; 42(24):8038-52. PubMed ID: 14632524
    [Abstract] [Full Text] [Related]

  • 14. Oligonuclear polypyridylruthenium(II) complexes incorporating flexible polar and non-polar bridges: synthesis, DNA-binding and cytotoxicity.
    Mulyana Y, Weber DK, Buck DP, Motti CA, Collins JG, Keene FR.
    Dalton Trans; 2011 Feb 21; 40(7):1510-23. PubMed ID: 21218244
    [Abstract] [Full Text] [Related]

  • 15. Contrasting reactivity and cancer cell cytotoxicity of isoelectronic organometallic iridium(III) complexes.
    Liu Z, Salassa L, Habtemariam A, Pizarro AM, Clarkson GJ, Sadler PJ.
    Inorg Chem; 2011 Jun 20; 50(12):5777-83. PubMed ID: 21618978
    [Abstract] [Full Text] [Related]

  • 16. Synthesis, interaction with DNA, cytotoxicity, cell cycle arrest and apoptotic inducing properties of ruthenium(II) molecular "light switch" complexes.
    Shobha Devi C, Anil Kumar D, Singh SS, Gabra N, Deepika N, Kumar YP, Satyanarayana S.
    Eur J Med Chem; 2013 Jun 20; 64():410-21. PubMed ID: 23665797
    [Abstract] [Full Text] [Related]

  • 17. Design of Ru-arene Complexes for Antitumor Drugs.
    Su W, Li Y, Li P.
    Mini Rev Med Chem; 2018 Jun 20; 18(2):184-193. PubMed ID: 28494728
    [Abstract] [Full Text] [Related]

  • 18. Discovery and investigation of anticancer ruthenium-arene Schiff-base complexes via water-promoted combinatorial three-component assembly.
    Chow MJ, Licona C, Yuan Qiang Wong D, Pastorin G, Gaiddon C, Ang WH.
    J Med Chem; 2014 Jul 24; 57(14):6043-59. PubMed ID: 25023617
    [Abstract] [Full Text] [Related]

  • 19. Synthesis, characterization, cytotoxicity, and hydrolytic behavior of C2- and C1-symmetrical Ti(IV) complexes of tetradentate diamine bis(phenolato) ligands: a new class of antitumor agents.
    Peri D, Meker S, Shavit M, Tshuva EY.
    Chemistry; 2009 Jul 24; 15(10):2403-15. PubMed ID: 19156656
    [Abstract] [Full Text] [Related]

  • 20. Luminescent cyclometalated iridium(III) polypyridine di-2-picolylamine complexes: synthesis, photophysics, electrochemistry, cation binding, cellular internalization, and cytotoxic activity.
    Lee PK, Law WH, Liu HW, Lo KK.
    Inorg Chem; 2011 Sep 05; 50(17):8570-9. PubMed ID: 21834537
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.